Arvinas Stock Analysis

ARVN
 Stock
  

USD 41.88  2.61  5.87%   

The small slide in market price for the last few months could raise concerns from institutional investors as the firm is trading at a share price of 41.88 on 135,921 in volume. The company executives did not add much value to Arvinas investors in September. However, diversifying your holdings with Arvinas or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.95. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Arvinas partners.
Please continue to Trending Equities.
  
The Arvinas stock analysis report makes it easy to digest most publicly released information about Arvinas and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Arvinas Stock analysis module also helps to analyze the Arvinas price relationship with some important fundamental indicators such as market cap and management efficiency.

Arvinas Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Arvinas was presently reported as 13.26. The company has Price/Earnings To Growth (PEG) ratio of 0.44. Arvinas recorded a loss per share of 3.02. The entity had not issued any dividends in recent years. Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people. For more info on Arvinas please contact John Houston at 203 535 1456 or go to https://www.arvinas.com.

Arvinas Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Arvinas' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Arvinas or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Arvinas generated a negative expected return over the last 90 days
Arvinas has high historical volatility and very poor performance
Arvinas has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 65.4 M. Net Loss for the year was (213.4 M) with profit before overhead, payroll, taxes, and interest of 46.7 M.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from beststocks.com: Best Pharmaceuticals Stocks for 2022 - Best Stocks

Arvinas Upcoming and Recent Events

Earnings reports are used by Arvinas to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Arvinas previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report7th of March 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End7th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Arvinas SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Arvinas prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Arvinas investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Arvinas specific information freely available to individual and institutional investors to make a timely investment decision.
19th of August 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
5th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
21st of June 2022
Submission of Matters to a Vote of Security Holders
View
16th of June 2022
Unclassified Corporate Event
View
9th of June 2022
Entry into a Material Definitive Agreement
View
16th of May 2022
Unclassified Corporate Event
View
5th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
28th of February 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View

Arvinas Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Arvinas is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arvinas backward and forwards among themselves. Arvinas' institutional investor refers to the entity that pools money to purchase Arvinas' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fmr LlcCommon Shares7.4 M309.9 M
Vanguard Group IncCommon Shares4.1 M171 M
Blackrock IncCommon Shares3.7 M154.7 M
Avidity Partners Management LpCommon Shares3.4 M141.2 M
Price T Rowe Associates IncCommon Shares3.3 M137.5 M
Ecor1 Capital LlcCommon Shares3.1 M131.5 M
Jpmorgan Chase CoCommon Shares2.2 M90.9 M
Note, although Arvinas' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arvinas Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 2.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arvinas's market, we take the total number of its shares issued and multiply it by Arvinas's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (12.3) % which means that it has lost $12.3 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (31.88) %, meaning that it created substantial loss on money invested by shareholders. Arvinas management efficiency ratios could be used to measure how well arvinas manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 3rd of October, Arvinas shows the Mean Deviation of 2.98, downside deviation of 3.81, and Risk Adjusted Performance of 0.038. Arvinas technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Arvinas, which can be compared to its rivals. Please confirm Arvinas variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Arvinas is priced correctly, providing market reflects its regular price of 41.88 per share. Given that Arvinas has jensen alpha of 0.3094, we suggest you to validate Arvinas's prevailing market performance to make sure the company can sustain itself at a future point.

Arvinas Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Arvinas price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
.

Arvinas Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Arvinas insiders, such as employees or executives, is commonly permitted as long as it does not rely on Arvinas' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Arvinas insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Young John D over a month ago via Macroaxis 
Acquisition by Young John D of 24572 shares of Arvinas subject to Rule 16b-3
Ronald Peck over a month ago via Macroaxis 
Exercise or conversion by Ronald Peck of 4010 shares of Arvinas subject to Rule 16b-3
Edward Kennedy over three months ago via Macroaxis 
Acquisition by Edward Kennedy of 10192 shares of Arvinas subject to Rule 16b-3
Briggs Morrison over three months ago via Macroaxis 
Exercise or conversion by Briggs Morrison of 16188 shares of Arvinas subject to Rule 16b-3
Ian Taylor over six months ago via Macroaxis 
Bona fide gift to Ian Taylor of 3000 shares of Arvinas subject to Section 16
Sean Cassidy over six months ago via Macroaxis 
Exercise or conversion by Sean Cassidy of 15000 shares of Arvinas subject to Rule 16b-3
Ronald Peck over six months ago via Macroaxis 
Acquisition by Ronald Peck of 67000 shares of Arvinas subject to Rule 16b-3
Ian Taylor over six months ago via Macroaxis 
Exercise or conversion by Ian Taylor of 1979 shares of Arvinas subject to Rule 16b-3
Ian Taylor over six months ago via Macroaxis 
Exercise or conversion by Ian Taylor of 20000 shares of Arvinas subject to Rule 16b-3
Edward Kennedy over six months ago via Macroaxis 
Arvinas exotic insider transaction detected
Ronald Peck over six months ago via Macroaxis 
Exercise or conversion by Ronald Peck of 5625 shares of Arvinas subject to Rule 16b-3
Sean Cassidy over six months ago via Macroaxis 
Exercise or conversion by Sean Cassidy of 15000 shares of Arvinas subject to Rule 16b-3

Arvinas Predictive Daily Indicators

Arvinas intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Arvinas stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Arvinas Forecast Models

Arvinas time-series forecasting models is one of many Arvinas' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arvinas' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Arvinas Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arvinas prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arvinas shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Arvinas. By using and applying Arvinas Stock analysis, traders can create a robust methodology for identifying Arvinas entry and exit points for their positions.
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut. Arvinas operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 280 people.

Current Arvinas Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arvinas analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arvinas analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
126.92Strong Buy13Odds
Arvinas current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Arvinas analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Arvinas stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Arvinas, talking to its executives and customers, or listening to Arvinas conference calls.
Arvinas Analyst Advice Details

Arvinas Stock Analysis Indicators

Arvinas stock analysis indicators help investors evaluate how Arvinas stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arvinas shares will generate the highest return on investment. By understating and applying Arvinas stock analysis, traders can identify Arvinas position entry and exit signals to maximize returns.
Quick Ratio6.03
Fifty Two Week Low34.90
Revenue Growth340.00%
Shares Short Prior Month4.91M
Average Daily Volume Last 10 Day362.79k
Average Daily Volume In Three Month392.66k
Shares Percent Shares Out9.62%
Gross Margins100.00%
Short Percent Of Float11.43%
Forward Price Earnings-8.72
Float Shares40.66M
Fifty Two Week High97.33
Enterprise Value To Ebitda-6.75
Fifty Day Average48.20
Two Hundred Day Average56.85
Enterprise Value To Revenue21.44
Please continue to Trending Equities. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for analysis

When running Arvinas price analysis, check to measure Arvinas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arvinas is operating at the current time. Most of Arvinas' value examination focuses on studying past and present price action to predict the probability of Arvinas' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arvinas' price. Additionally, you may evaluate how the addition of Arvinas to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Arvinas' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine Arvinas value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.